exhaust
cell
increas
product
wellknown
chronic
viral
infect
mechan
lead
loss
cytotox
capabl
consequ
exhaust
remain
unclear
exhaust
cell
also
call
suppressor
highli
immun
suppress
alter
cell
receptor
signal
characterist
mark
exclus
cytotox
counterpart
studi
found
ica
flux
reduc
follow
cell
receptor
activ
suppressor
cell
compar
effector
counterpart
importantli
chronic
activ
murin
cytotox
cell
lead
reduc
ica
influx
decreas
enhanc
product
profil
mimick
cell
upon
reduct
ica
flux
extracellular
calcium
channel
inhibitor
reduc
ica
flux
induc
ro
lead
reduct
increas
produc
suppressor
axi
find
substanti
human
data
reduc
ica
flux
chronic
hepat
infect
display
cell
low
increas
product
importantli
treatment
antioxid
led
increas
reduc
product
human
chronic
hepbc
sampl
suggest
overal
proxim
regulatori
role
ica
influx
ro
determin
effector
suppress
axi
cell
cytotox
cell
cell
subset
play
crucial
role
clear
viral
infect
activ
secret
cytolyt
molecul
proinflammatori
cytokin
specif
perforin
gr
b
howev
persist
antigen
presenc
evidenc
chronic
viral
infect
hepat
bc
hiv
lead
cell
exhaust
character
sustain
high
express
surfac
inhibitori
marker
subsequ
loss
cytotox
capabl
elev
level
also
report
infect
multipl
studi
report
direct
link
loss
cytotox
increas
level
switch
cytokin
product
also
accompani
alter
express
key
transcript
factor
tbet
eomesodermin
indic
complet
phenotyp
chang
cytotox
cell
suppressor
sup
phenotyp
inevit
domin
suppressor
phenotyp
advers
patholog
consequ
limit
intra
cellular
infect
also
gener
immun
homeostasi
subsequ
alter
cytotox
cell
balanc
complet
break
immun
respons
exagger
suppress
partial
restor
cytotox
function
exhaust
cell
report
blockad
coinhibitori
receptor
well
receptor
lymphocyt
choriomening
toxoplasma
gondii
howev
exact
signal
pathway
lead
convers
effector
cell
suppressor
phenotyp
yet
undefin
importantli
elucid
pathway
exhaust
pave
way
target
regulatori
molecul
may
help
complet
restor
function
suppressor
cell
differ
type
sup
cell
execut
suppressor
function
follow
mechan
antiinflammatori
cytokin
product
cellcel
contact
mediat
suppress
cytotox
target
cell
competit
consumpt
exampl
sup
cell
execut
function
render
apc
tolerogen
alloantigeninduc
sup
cell
suppress
cell
prolifer
cell
cell
contact
depend
mechan
sup
cell
function
also
natur
occur
sup
cell
function
antiinflammatori
cytokin
studi
primarili
focus
immun
suppress
antiinflammatori
cytokin
princip
aim
studi
effect
chronic
infect
tcr
downstream
signal
event
eventu
convert
proinflammatori
cytokin
produc
effector
cell
antiinflammatori
cytokin
produc
sup
cell
ica
flux
ro
two
earliest
signal
event
downstream
tcr
activ
ica
flux
dynam
report
decod
differenti
cytokin
product
quantiti
ro
known
effect
proantiinflammatori
cytokin
product
signal
pathway
cell
cell
activ
cell
receptor
tcr
upon
antigen
present
result
elev
ica
flux
contribut
ca
releas
endoplasm
reticulum
ca
influx
crac
channel
extracellular
sourc
increas
window
ica
known
requir
transloc
nucleu
transcript
gr
b
whose
secret
impair
chronic
infect
interestingli
suppressor
cell
known
induc
function
suppress
cell
produc
ro
tumor
microenviron
apart
coinhibitori
receptor
also
lead
increas
cellular
ro
reduc
upon
blockad
importantli
interplay
ica
flux
ro
known
posit
neg
regul
number
signal
pathway
depend
upon
cell
type
yet
explor
chronic
viral
infect
consid
aforement
fact
studi
ica
flux
ro
interplay
convert
proinflammatori
respons
abbrevi
bep
bepridil
hydrochlorid
amlo
amlodipin
besyl
thap
thapsigargin
ac
acut
ch
chronic
antiinflammatori
respons
observ
reduc
ica
flux
lead
increas
ro
product
turn
produc
higher
lower
chronic
activ
cell
axi
wherea
induct
ro
affect
ica
flux
indic
proxim
regulatori
role
ica
flux
chronic
hepbc
sampl
also
display
reduc
ica
flux
increas
ro
compar
acut
counterpart
intriguingli
treatment
ro
scaveng
abl
reduc
product
increas
cell
chronic
hepbc
sampl
taken
togeth
data
suggest
proxim
regulatori
role
ica
influx
ro
determin
effector
suppress
axi
cell
wild
type
strain
balbcj
ko
mice
obtain
jackson
laboratori
bar
harbor
nation
institut
immunolog
new
delhi
india
imgenex
bhubaneswar
india
maintain
cycl
pathogen
free
anim
facil
institut
life
scienc
bhubaneswar
food
water
provid
adlibitum
age
sex
match
inbr
wild
type
balbcj
ko
mice
use
experi
il
institut
anim
ethic
committe
approv
present
studi
cytokin
murin
purchas
prospec
rehovot
israel
recombin
human
imgenex
corpor
san
diego
ca
usa
antibodi
activ
cytokin
neutral
procur
bioxcel
usa
fluoresc
antibodi
includ
apcalexa
tbet
pe
granzymeb
pe
perforinapc
eomesfitc
intracellular
surfac
stain
purchas
ebiosci
san
diego
ca
usa
bd
bioscienc
san
jose
ca
usa
bio
legend
san
diego
ca
usa
antibodi
confoc
microscopi
purchas
cell
signal
technolog
danver
usa
chemic
includ
phorbol
ionomycin
brefeldin
bepridil
hydrochlorid
amlodipin
besyl
thapsigargin
edta
obtain
sigma
inc
usa
institut
human
ethic
committe
il
bhubaneswar
sum
hospit
bhubaneswar
odisha
approv
sanction
present
studi
briefli
blood
sampl
human
healthi
volunt
acut
n
chronic
hep
b
n
patient
collect
recruit
healthi
subject
base
inclusionexclus
criteria
hep
b
subject
base
confirmatori
clinic
diagnosi
test
acut
chronic
hepb
patient
confirm
clinic
partner
chronic
patientshbsag
posit
month
serum
hbv
dna
copiesml
persist
intermitt
increas
altast
level
sampl
collect
control
hep
b
subject
inform
consent
data
control
hep
b
volunt
depict
figur
viral
load
signal
cut
ratio
alkalin
phosphatas
glutamicoxalacet
transaminas
sgot
glutamicpyruv
transaminas
sgpt
also
assay
confirm
co
relat
infect
statu
extent
liver
damag
cell
isol
spleen
lymph
node
week
old
mice
neg
select
use
dynal
bead
invitrogen
usa
accord
manufactur
protocol
cell
puriti
check
flow
cytometri
consist
around
isol
cell
cultur
rpmi
supplement
fetal
bovin
serum
australian
origin
panbiotech
uml
penicillin
ugml
streptomycin
mm
sigma
differenti
cell
x
concentr
activ
plate
bound
anti
ugml
anti
ugml
provid
ngml
mgml
iuml
ad
h
day
cell
remov
activ
signal
rest
day
iuml
h
chronic
activ
differenti
cell
plate
cellsml
everi
third
day
plate
bound
anti
ugml
anti
ugml
day
supplement
iuml
day
cell
remov
activ
signal
rest
day
iuml
h
cell
wash
rpmi
media
use
subsequ
experi
indic
cytotox
cell
tc
differenti
state
confirm
detect
signatur
transcript
factor
cytokin
flow
cytometri
differenti
cytotox
cell
ml
reactiv
ngml
pma
ugml
ionomycin
h
detect
intracellular
cytokin
transcript
factor
surfac
marker
ugml
brefeldina
ad
cultur
last
h
dead
cell
exclud
use
live
dead
fixabl
violet
dead
cell
stain
kit
invitrogen
usa
intracellular
cytokin
stain
perform
use
cytofixcytoperm
fixationpermeabil
solut
kit
bd
bioscienc
san
jose
ca
usa
transcript
factor
stain
perform
use
stain
buffer
set
ebiosci
san
diego
ca
usa
accord
manufactur
instruct
inhibitor
studi
cell
incub
mention
inhibitor
min
prior
stimul
pmaion
antibodi
use
alexa
flour
alexa
fluor
efluor
fluor
anti
erk
anti
pe
antibodi
includ
correspond
isotyp
purchas
ebiosci
san
diego
ca
usa
bd
pharmingen
san
jose
ca
data
acquir
bdlsr
ii
bd
bioscienc
san
jose
ca
usa
analyz
fac
diva
softwar
intracellular
stain
cell
stimul
pmaion
h
fix
formaldehyd
min
room
temperatur
cell
permeabil
icecold
methanol
vigor
vortex
follow
incub
c
min
cell
wash
stain
antibodi
h
c
cytotox
suppressor
cell
differenti
confirm
accord
protocol
describ
follow
activ
cell
h
wash
pb
fix
min
cell
wash
remov
fixat
buffer
follow
permeabil
stain
primari
antibodi
anti
ice
follow
secondari
antibodi
alexa
flour
unbound
extra
antibodi
wash
nuclei
stain
dapi
dark
min
thereaft
transloc
nucleu
check
tc
leica
confoc
microscop
use
nm
laser
calcium
kinet
assay
cell
stain
um
incub
min
room
temperatur
follow
wash
dpb
wo
ca
mg
remov
unbound
excess
stain
final
suspend
dpb
ca
mg
base
line
valu
ica
flux
acquir
min
cell
treat
um
bepridil
hydrochlorid
nm
nm
amlodipin
mm
edta
min
follow
tcr
stimul
pmaion
ca
kinet
acquir
total
min
bdlsrii
bd
bioscienc
nm
analyz
flowjo
softwar
also
experi
secondari
crosslink
anti
found
similar
trend
pmaion
identifi
express
cytotox
molecul
includ
granzymeb
perforin
differenti
cytotox
cell
x
ml
reactiv
ngml
pma
ugml
ionomycin
h
ugml
brefeldina
ad
cultur
last
h
dead
cell
exclud
use
live
dead
fixabl
violet
dead
cell
stain
kit
nm
excit
invitrogen
usa
intracellular
cytokin
stain
perform
use
cytofixcytoperm
fixationpermeabil
solut
kit
per
manufactur
protocol
antibodi
use
antigranzym
bpe
antiperforin
apc
data
acquir
bd
lsr
ii
bd
bioscienc
analyz
fac
diva
softwar
intracellular
ro
level
measur
use
oxid
sensit
fluoresc
dye
dihydroethidium
dhe
detect
intracellular
superoxid
differenti
cell
preload
dhe
um
min
medium
without
serum
cell
wash
pb
treat
indic
concentr
menadion
min
without
nac
mm
case
cell
treat
menadion
indic
concentr
um
min
dhe
um
ad
cultur
incub
min
incub
cell
wash
resuspend
pb
oxid
dhe
detect
use
flow
cytomet
intracellular
stain
human
unstimul
stimul
cell
fix
formaldehyd
final
concentr
min
room
temperatur
permeabil
icecold
methanol
vigor
vortex
incub
c
h
wash
stain
media
pb
bsa
cell
stain
respect
antibodi
h
room
temperatur
sampl
acquir
flow
cytomet
assess
function
chronic
activ
cell
cell
taken
millionml
concentr
cocultur
cell
target
cell
ratio
stimul
pma
ngml
ion
ugml
h
cell
label
um
cfse
incub
cell
stain
live
dead
fixabl
violet
dead
cell
stain
kit
nm
excit
invitrogen
usa
cell
analyz
loss
cfse
dcd
presenc
absenc
pmaion
treatment
withwithout
cell
effector
cell
cell
taken
millionml
concentr
stimul
pmaion
previous
describ
recombin
mous
prospec
israel
ad
exogen
ngml
ngml
concentr
incub
h
bfa
ad
ugml
concentr
h
incub
cell
stain
antibodi
acquir
analyz
bd
lsr
fortessa
statist
analysi
perform
use
twoway
anova
follow
bonferroni
multipl
comparison
test
compar
multipl
group
mannwhitney
u
test
perform
human
sampl
use
prism
graph
pad
la
jolla
ca
usa
examin
confirm
loss
cytotox
function
gain
immunesuppress
memori
effector
cell
chronic
hepb
patient
figur
gate
cell
describ
figur
primarili
establish
chronic
infectionsactiv
sever
impair
cytotox
cell
function
whilst
convert
suppressor
phenotyp
cell
isol
acut
hepb
patient
activ
secret
p
clearli
contrast
cell
deriv
chronic
hepb
patient
n
secret
higher
p
figur
e
f
cytokin
analys
control
acut
effector
memori
compart
clearli
demonstr
significantli
higher
p
acut
compart
figur
surprisingli
product
effector
memori
compart
two
significantli
higher
p
chronic
counterpart
wherea
though
antiinflammatori
cytokin
product
significantli
higher
p
effector
compart
cell
isol
chronic
hepb
patient
differ
insignific
figur
memori
compart
suggest
cytotox
effector
function
effector
compart
affect
direct
contrast
control
subject
display
strong
cytotox
phenotyp
similar
product
acut
subject
figur
c
suggest
earli
appropri
cytotox
respons
phase
regress
analysi
determin
analyz
relationship
product
display
invers
relationship
chronic
hep
b
figur
howev
regress
analysi
control
acut
hepb
patient
show
weak
relationship
two
cytokin
thu
data
suggest
cytotox
cell
capabl
mayb
progress
lost
chronic
hepb
infect
concomit
increas
product
turn
could
reduc
pro
inflammatori
statu
contribut
persist
infect
undetect
pathogen
basal
presenc
control
human
aid
convers
block
activ
cell
seen
control
acut
hep
b
patient
compar
product
notic
effector
compart
acut
patient
crucial
suggest
chronic
immin
immun
suppress
thu
implicit
result
simpl
reduct
increas
product
viral
infect
alon
lead
suppress
immun
system
diseas
chronic
postacut
chronic
infect
confirm
examin
earli
tcr
downstream
event
dictat
switch
cytotox
respons
immun
suppress
one
compar
ica
influx
figur
earli
tcr
downstream
signal
event
follow
cell
activ
acut
chronic
hepat
b
hep
b
hepat
c
hep
c
data
shown
patient
cell
base
control
first
examin
neg
select
cell
healthi
control
ica
influx
figur
challeng
without
pmaion
tcr
activ
secondari
crosslink
surprisingli
cell
display
robust
ica
influx
figur
co
relat
well
cytokin
respons
figur
b
compar
ca
kinet
follow
pmaion
chronic
hep
b
hep
c
patient
acut
counterpart
show
cell
ica
influx
complet
abrog
chronic
patient
resembl
unstimul
control
figur
b
increas
switch
immunosuppress
profil
also
co
relat
well
clinic
diagnost
enzym
profil
includ
alkalin
phosphatas
alanin
transaminas
aspart
transaminas
ast
figur
reduc
ica
influx
chronic
hep
b
hep
c
deriv
cell
suggest
signific
chang
earli
tcr
downstream
event
specif
ica
influx
follow
persist
viral
infect
frontier
immunolog
wwwfrontiersinorg
figur
impair
ica
influx
chronic
hep
bc
patient
cell
control
isol
stimul
presenc
absenc
pmaionomycin
examin
basal
stimul
ica
influx
unstimul
us
cell
control
display
ica
influx
compar
pmaionomycin
stimul
cell
isol
control
acut
chronic
hep
bhep
c
patient
follow
stain
ica
influx
record
min
upon
pmaion
stimul
effect
prosuppress
cytokin
secret
data
includ
data
lab
indic
durat
amplitud
frequenc
concentr
ica
flux
could
lead
differenti
signal
outcom
dissect
tcr
activ
ica
influx
could
regul
product
establish
cytotox
suppressor
phenotyp
figur
neg
select
murin
cell
signatur
cytokin
transcript
factor
cytolyt
protein
surfac
coreceptor
includ
tbet
eomesodermin
gr
b
perforin
examin
establish
monitor
classic
acut
activ
day
cytotox
cell
chronic
activ
day
suppressor
phenotyp
mention
multiparamet
abl
establish
said
phenotyp
examin
cytotox
cell
defin
interv
amongst
chronic
activ
profil
day
chosen
paramet
studi
show
signific
loss
cytotox
gain
immun
suppress
report
p
gr
b
p
perforin
express
significantli
reduc
chronic
activ
compar
acut
counterpart
figur
b
e
g
also
abil
kill
target
cell
cell
significantli
reduc
compar
acut
counterpart
figur
cell
cocultur
cell
compar
counterpart
sampl
test
signific
use
twoway
anova
p
p
p
p
consid
signific
frontier
immunolog
wwwfrontiersinorg
confirm
chronic
activ
induc
loss
function
cell
concomitantli
express
surfac
coinhibitori
receptor
p
significantli
increas
thu
confirm
loss
cytotox
capabl
gain
immun
suppress
figur
k
increas
express
surfac
inhibitori
receptor
loss
inflammatori
cytokin
cytotox
protein
relat
transcript
factor
exhaust
cell
chronic
activ
indic
gradual
cell
exhaust
due
persist
ex
vivo
activ
reduct
proinflammatori
cytokin
correl
well
reduc
express
master
transcript
factor
tbet
figur
h
process
accompani
increas
secret
antiinflammatori
cytokin
figur
f
analysi
also
suggest
even
though
tbet
figur
popul
significantli
reduc
chronic
activ
figur
popul
also
increas
significantli
compar
acut
counterpart
could
clearli
attribut
significantli
higher
express
also
found
figur
significantli
increas
compar
acut
counterpart
suggest
produc
cell
express
coinhibitori
receptor
marker
cell
exhaust
chronic
activ
result
suggest
chronic
activ
cell
may
alter
downstream
tcr
signal
event
eventu
lead
phenotyp
chang
subtyp
suppressor
type
flip
proinflammatori
cytokin
antiinflammatori
cytokin
significantli
paramet
chang
allow
us
monitor
confirm
loss
cytotox
gain
immun
suppress
function
cell
delin
differenti
signal
cascad
follow
tcr
activ
lead
switch
secret
first
compar
ica
influx
one
proxim
signal
event
follow
tcr
activ
hypothesi
base
earlier
studi
establish
dynam
ica
flux
decid
factor
signal
outcom
observ
ica
influx
significantli
higher
acut
compar
chronic
counterpart
figur
b
ica
concentr
given
period
time
assay
area
curv
depict
decreas
ica
concentr
chronic
activ
cell
compar
acut
counterpart
figur
b
significantli
stimul
increas
unstimul
control
chronic
stimul
cell
almost
neglig
strongli
suggest
complet
insensit
near
shut
ica
influx
result
suggest
ica
influx
downstream
tcr
signal
alter
chronic
activ
could
significantli
impact
cytotox
function
consequ
also
check
wide
report
ca
depend
transcript
factor
secret
cell
nuclear
transloc
assay
determin
effect
reduc
window
ica
surprisingli
found
transloc
nucleu
significantli
reduc
chronic
activ
cell
figur
thu
infer
result
reduc
tbet
express
figur
l
reduc
ica
influx
could
alter
product
transcript
level
perform
transloc
studi
chronic
activ
cell
deriv
ko
mice
figur
f
found
signific
transloc
compar
wild
type
ko
transloc
studi
clearli
prove
distal
respons
neg
regul
transloc
subsequ
product
taken
togeth
result
show
intric
ica
axi
fine
regul
transloc
nucleu
subsequ
product
possibl
involv
convers
cytotox
cell
suppressor
phenotyp
chronic
activ
cytotox
cell
lead
loss
cytotox
function
gain
immun
suppress
capabl
mark
alter
ica
influx
signific
decreas
gr
b
increas
role
gave
proof
strengthen
hypothesi
ica
axi
balanc
cytotox
immun
suppress
defin
differenti
signal
cascad
ascertain
regulatori
role
ica
dynam
follow
tcr
activ
lead
switch
proinflammatori
cytokin
secret
antiinflammatori
cytokin
alter
ica
influx
specif
inhibitor
examin
ica
role
one
proxim
tcr
signal
event
amongst
sever
inhibitor
use
bepridil
hydrochlorid
bep
nonselect
plasma
membran
calcium
channel
inhibitor
crac
channel
inhibitor
signific
inhibitori
effect
reduct
ica
influx
figur
b
though
bepridil
hydrochlorid
reduc
gr
b
product
figur
reduct
amlo
tg
signific
suggest
ica
flux
extracellular
calcium
channel
play
signific
role
proinflammatori
cytokin
product
also
found
wherea
proinflammatori
cytokin
significantli
reduc
antiinflammatori
cytokin
increas
prove
modul
ica
flux
simpli
shut
cellular
process
product
increas
bep
increas
record
respect
suggest
fine
tune
ica
flux
regul
product
upon
inhibit
specif
calcium
channel
also
found
extracellular
calcium
channel
inhibit
bep
led
significantli
reduc
grb
express
figur
wherea
inhibit
intracellular
calcium
channel
amlo
tg
effect
grb
express
figur
suggest
gr
b
reduct
invers
co
relat
product
product
higher
bep
grb
express
reduc
significantli
express
unaffect
absenc
significantli
higher
intracellular
calcium
channel
inhibit
result
togeth
suggest
inhibit
ica
influx
acut
activ
could
mimic
chronic
activ
profil
respect
gr
b
product
also
strongli
suggest
neg
regul
gr
b
express
cell
signific
loss
cytotox
protein
gr
b
perforin
confirm
semin
direct
role
ica
influx
establish
propag
cytotox
function
switch
product
use
ica
influx
inhibitor
complement
complet
semin
role
significantli
result
ica
influx
inhibitor
ica
influx
profil
chronic
activ
cell
clearli
suggest
exquisit
corel
ica
influx
pro
antiinflammatori
cytokin
product
cytotox
suppressor
cell
shown
sampl
test
signific
use
twoway
anova
p
p
p
p
consid
signific
enhanc
cytotox
impair
ica
influx
insensit
ica
channel
chronic
activ
ko
mice
cell
execut
cytotox
function
mean
cytotox
molecul
includ
amongst
other
gr
b
perforinc
whose
function
report
impair
chronic
infect
combin
function
gr
b
perforinc
respons
function
execut
cytotox
cell
examin
gr
b
express
chronic
activ
ko
mice
ica
influx
inhibitor
ex
vivo
acut
activ
demonstr
direct
correl
complet
revers
relationship
chronic
activ
figur
absenc
neg
feedback
regul
gr
b
product
significantli
elev
importantli
express
effect
ica
influx
inhibitor
figur
found
secret
increas
acut
chronic
even
day
activ
product
sustain
express
gr
b
perforinc
also
highli
signific
increas
acut
chronic
activ
significantli
report
ica
influx
significantli
lower
chronic
activ
cell
compar
acut
counterpart
ko
mice
figur
interestingli
tbet
express
also
regul
ko
mice
confirm
loss
neg
feedback
loop
regul
figur
b
also
confirm
semin
singular
role
regul
immun
respons
regul
wild
type
ko
mice
suggest
signal
alon
becom
redund
absenc
result
crucial
establish
proxim
ica
influx
follow
tcr
activ
downstream
product
exquisit
exclus
downregul
proinflammatori
statu
cytotox
cell
proxim
ica
influx
inhibit
inhibitori
effect
gr
b
perforinc
absenc
evidenc
ko
experi
suggest
alon
distal
effector
immun
suppress
regul
thu
result
show
ica
axi
play
critic
role
modul
finetun
cytotox
immun
respons
activ
chronic
infect
importantli
downstream
alon
determin
loss
cytotox
immun
suppress
finetun
mandatorili
determin
earli
antigen
present
ko
data
suggest
complet
absenc
lead
higher
product
even
cell
strongli
suggest
central
role
downregul
immun
respons
therefor
confirm
establish
role
import
immun
respons
downregul
use
exogen
recombin
ngml
ngml
concentr
surprisingli
result
show
minim
insignific
reduct
figur
j
suggest
exogen
alon
absenc
antigen
mediat
regulatori
pathway
insuffici
result
valid
hypothesi
tcr
signal
mediat
immun
respons
extrem
fine
tune
inflammatori
anti
inflammatori
respons
determin
establish
earli
ca
flux
ro
stat
cell
plastic
establish
regulatori
role
ica
influx
examin
role
reactiv
oxygen
speci
ro
antioxid
regul
phenotyp
chang
termin
differenti
cytotox
cell
cell
chronic
viral
infect
result
reveal
induct
ro
affect
ica
flux
figur
wherea
reduct
ica
flux
bep
increas
ro
concentr
figur
b
indic
ica
flux
work
upstream
ro
importantli
comparison
ro
concentr
acut
chronic
activ
cell
reveal
chronic
activ
produc
higher
amount
ro
compar
acut
counterpart
brought
treatment
antioxid
nac
figur
e
f
investig
reduc
ca
flux
influenc
jakstat
pathway
result
reveal
crac
channel
inhibit
increas
express
bep
increas
express
figur
indic
involv
ro
calcium
regul
produc
antiinflammatori
pathway
axi
data
suggest
reduc
ica
flux
increas
ro
lead
posit
treatment
menadion
ro
induc
reduc
doubl
posit
popul
significantli
nac
treatment
partial
revers
trend
establish
certain
plastic
cytotox
cell
ro
figur
interestingli
hand
menadion
treatment
increas
express
significantli
complet
restor
nac
figur
j
comparison
result
chronic
activ
cell
reveal
dual
increas
although
express
much
affect
interestingli
treatment
chronic
activ
cell
ro
scaveng
reduc
product
figur
result
indic
differenti
role
stabil
suppressor
phenotyp
crucial
ro
ica
flux
could
alter
cell
phenotyp
proof
principl
examin
cell
acut
chronic
hepb
patient
data
suggest
treatment
cell
nac
acut
hepbc
patient
lead
reduc
product
figur
r
nac
treatment
chronic
activ
lead
increas
product
product
reduc
reduct
product
acut
hepbc
infect
indic
window
cellular
ro
requir
product
express
significantli
alter
hand
elev
ro
level
requir
product
taken
togeth
data
suggest
reduc
ica
flux
lead
increas
ro
product
turn
express
axi
lead
impair
immun
respons
chronic
infect
chronic
intra
cellular
infect
caus
unproduct
immun
respons
virus
continu
ineffici
activ
lead
cell
exhaust
wherebi
lose
abil
secret
proinflammatori
cytokin
cytolyt
protein
cell
known
import
clearanc
viral
infect
secret
cytolyt
molecul
gr
b
perforinc
shown
chang
phenotyp
secret
compromis
cytotox
statu
shown
precipit
chronic
viral
infect
blockad
ablat
treg
cell
known
rescu
exhaust
cell
chronic
viral
infect
indic
suppress
role
impair
immun
respons
interestingli
exhaust
cell
extens
character
proxim
signal
pathway
post
tcr
activ
exhaust
cell
convert
still
undefin
result
show
direct
link
alter
ica
influx
ro
transloc
flip
pro
antiinflammatori
cytokin
provid
strong
evid
ica
influx
nexu
dictat
convers
effector
cell
suppress
subset
axi
chronic
activ
cytotox
cell
subvert
cytotox
capabl
immunesuppress
type
result
accord
previou
studi
progress
gradual
flip
proinflammatori
cytotox
cell
type
gener
acut
activ
antiinflammatori
immun
suppressor
cell
type
encount
chronic
activ
seen
murin
human
cell
flip
cytotox
suppressor
phenotyp
evidenc
even
transcript
level
cytotox
signatur
transcript
factor
tbet
express
apart
gr
b
markedli
reduc
signal
cascad
downstream
tcr
activ
requir
two
function
differ
cytokin
quit
differ
hypothes
chronic
activ
would
necessit
complet
chang
tcr
downstream
signal
event
cell
convers
suppressor
type
ica
influx
along
ro
mark
two
figur
reduct
ica
flux
acut
chronic
activ
increas
ro
product
differenti
cell
preload
dhe
um
min
medium
without
serum
cell
wash
pb
treat
indic
concentr
menadion
min
without
nac
mm
case
cell
treat
menadion
indic
concentr
min
dhe
um
ad
cultur
incub
min
incub
cell
wash
resuspend
pb
oxid
dhe
detect
flow
cytometri
inhibit
ica
flux
bep
increas
ro
product
cell
b
cell
produc
higher
ro
compar
acut
counterpart
reduc
follow
nac
treatment
c
e
f
treatment
menadion
effect
calcium
influx
g
ii
differenti
cell
treat
um
menadion
without
mm
nac
incub
cell
stain
molecul
cell
treat
mm
nac
h
menadion
treatment
reduc
product
significantli
rescu
upon
nac
treatment
j
express
increas
upon
menadion
treatment
lower
significantli
upon
treatment
nac
cell
express
significantli
higher
compar
cell
k
l
p
increas
express
follow
treatment
calcium
channel
inhibitor
bep
n
product
reduc
follow
treatment
antioxid
nac
acut
hepb
wherea
chronic
hepb
increas
reduc
product
q
r
sampl
test
signific
use
twoway
anova
p
p
p
p
consid
signific
earliest
signal
event
downstream
tcr
activ
report
dynam
ica
ro
cell
lead
differenti
cytokin
product
data
present
suggest
ica
flux
reduc
ro
increas
significantli
chronic
activ
murin
persist
human
infect
clearli
co
relat
immun
suppress
profil
chang
proxim
ica
influx
ro
use
ica
inhibitor
oxidantanti
oxid
acut
activ
chronic
activ
mice
cell
persist
infect
human
clearli
regul
proinflammatori
cytokin
regul
product
crucial
comprehens
loss
sensit
ica
influx
inhibit
cell
ko
mice
impli
mandatori
requir
presenc
cours
immun
respons
addit
complet
unaffect
nuclear
transloc
chronic
activ
cell
ko
mice
strongli
suggest
proxim
ica
influx
distal
axi
regul
cytotox
loss
genet
alter
mice
use
clearli
demonstr
connect
ica
influx
distal
transloc
subsequ
cytotox
dysregul
chronic
activ
lead
exacerb
cytotox
point
mandatori
requir
finetun
immun
respons
infect
addit
inher
capabl
convert
cytotox
cell
suppressor
phenotyp
ica
influx
inhibit
mark
pivot
step
regul
uncontrol
accident
cytotox
respons
may
even
oper
physiolog
semin
point
crucial
find
chronic
activ
infect
complet
inhibit
cell
ica
influx
mark
earli
diagnost
marker
distinguish
cytotox
immun
suppress
statu
cell
proof
principl
establish
mous
human
studi
give
signific
credenc
find
notabl
inhibitor
studi
ica
influx
reduc
nonselect
plasma
membran
calcium
channel
inhibitor
bepridil
hydrochlorid
crac
channel
inhibitor
direct
co
relat
reduc
gr
b
significantli
increas
product
contrastingli
inhibit
intracellular
calcium
channel
ryanodin
receptor
serca
pump
amlodipin
besyl
thapsigargin
neither
ica
product
affect
signific
product
suggest
ica
plasma
membran
crac
channel
critic
tcr
downstream
signal
event
lead
inhibit
pro
inflammatori
product
antiinflammatori
cytokin
crucial
ica
influx
affect
gr
b
product
unaffect
impli
tcr
mediat
earli
ica
influx
plasma
membran
crac
channel
determin
cytotox
result
cell
activ
profil
ica
inhibitor
ko
mice
human
sampl
clearli
demonstr
implicit
direct
co
relat
ica
influx
cytotox
inhibit
ica
influx
explicitli
associ
chronic
activ
result
gain
immun
suppress
phenotyp
except
absent
suggest
distal
mediat
immun
suppress
induct
ro
menadion
subtyp
led
signific
increas
reduc
tbet
product
reciproc
cytokin
chang
accompani
alter
express
intriguingli
treatment
antioxid
nac
restor
tbet
popul
reduc
popul
restor
product
indic
involv
signal
molecul
interestingli
inhibit
ica
flux
also
display
higher
ro
express
substanti
relationship
ica
flux
ro
stat
molecul
known
respons
product
key
effector
molecul
suppressor
execut
function
requir
boost
immunesuppress
function
treg
cell
surprisingli
chronic
activ
cell
also
display
higher
ro
substanti
hypothesi
increas
ro
decreas
ica
flux
led
suppressor
subtyp
ica
flux
act
upstream
ro
induct
ro
nt
effect
ica
flux
wherea
reduc
ica
flux
increas
ro
signific
latent
find
studi
underst
semin
role
immun
regul
suppress
abnorm
high
express
tbet
gr
b
perforinc
ko
mice
wild
type
mice
clearli
suggest
critic
role
play
immun
regul
fine
tune
immun
respons
even
significantli
increas
protein
complet
incompet
immun
suppress
cell
suggest
cardin
singular
role
immun
regul
absenc
studi
compound
earlier
interpret
suppos
role
protein
consid
earlier
human
studi
also
shown
need
necessarili
mark
exhaust
howev
complet
inhibit
ica
influx
profil
chronic
activ
cell
complet
insensit
ica
influx
inhibitor
ko
deriv
one
suggest
ica
influx
finetun
immun
respons
loss
may
lead
sever
uncontrol
cytotox
inflamm
subsequ
immunepatholog
suppress
function
secret
result
convers
effector
cell
sup
cell
follow
chronic
tcr
stimul
antigen
specif
contrari
produc
cocultur
cell
natur
cell
case
sup
cell
execut
function
contact
independ
gener
suppress
activ
sup
cell
gener
studi
signific
case
chronic
infect
phenomena
lead
signific
reduct
effector
cell
requir
clear
infect
importantli
moreov
convert
sup
cell
also
affect
gener
immun
homeostasi
inhibit
strong
respons
addit
produc
effector
cell
primarili
inhibit
convert
produc
sup
cell
amongst
transcript
factor
tbet
studi
report
tbet
signatur
transcript
factor
type
reduc
significantli
chronic
activ
signatur
transcript
factor
treg
type
majorli
alter
chronic
activ
use
inhibitor
seem
reflect
immun
suppress
function
capabl
suppressor
addit
though
tbet
express
reduc
chronic
activ
ica
influx
inhibitor
reduc
express
significantli
acut
activ
conclud
reduct
ica
influx
inhibitor
could
tbet
independ
acut
activ
product
cell
could
differ
pathway
elicit
treg
type
hypothes
time
period
calcium
channel
inhibit
acut
activ
may
suffici
enough
affect
treg
transcript
requir
regul
affect
gr
b
level
singl
relev
studi
proof
principl
demonstr
acut
chronic
infect
human
hepat
b
found
ica
influx
cell
complet
abrog
signific
increas
decreas
amongst
cell
compart
examin
chronic
hep
b
patient
memori
effector
cell
demonstr
clear
bia
compar
acut
counterpart
control
importantli
regress
analysi
show
neg
regul
product
chronic
hepb
significantli
treatment
antioxid
nac
restor
product
reduc
level
role
pathogenesi
hepatitisb
paradox
author
report
effector
cellderiv
enhanc
acut
liver
immunopatholog
wherea
other
report
mediat
liver
immunopatholog
chronic
hepb
infect
indian
popul
tb
infect
strong
respons
mandatori
viral
clearanc
collater
damag
minim
damag
allow
pathogen
grow
albeit
slowli
hep
b
howev
sinc
viral
replic
high
secret
cell
allow
viral
clearanc
subsequ
lead
liver
patholog
robust
respons
would
allow
viral
clearanc
mandat
viral
infect
clearanc
summari
studi
demonstr
reduc
ica
influx
lead
product
suppress
cytokin
gr
b
express
regul
studi
human
hep
b
sampl
good
corel
murin
data
suggest
ica
influx
could
use
potenti
diagnost
marker
cytotox
suppressor
cell
human
clinic
data
store
sum
hospit
author
request
ethic
legal
privaci
consent
request
doctor
patient
share
data
mous
data
made
avail
research
request
studi
involv
anim
carri
accord
recommend
committe
purpos
control
supervis
experi
anim
cpcsea
il
anim
ethic
committe
mice
taken
il
anim
hous
per
institut
guidelin
sm
design
carri
analyz
experi
prepar
manuscript
pb
prepar
handl
human
sampl
nd
perform
clinic
diagnosi
handl
human
sampl
pn
prepar
ko
mice
confirm
design
ko
experi
input
sd
design
analyz
experi
prepar
manuscript
provid
overal
supervis
